Buchen, L. (2011). Cell signaling caught in the act. Nature, 475, 273–274. (Human interest account of Brian Kobilka’s work.)

Gosnell, B. A., and Levine, A. S. (2009). Reward systems and food intake: Role of opioids. Int. J. Obes. (Lond.), 33 (Suppl. 2), S54–S58.

Gruber, S. A., Silveri, M. M., and Yurgelun-Todd, D. A. (2007). Neuropsychological consequences of opioid use. Neuropsychol. Rev., 17, 299–315.

Javelot, H., Messaoudi, M., Garnier, S., and Rougeot, C. (2010). Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways. J. Physiol. Pharmacol., 61, 355–362.

Lobmaier, P., Gossop, M., Waal, H., and Bramness, J. (2010). The pharmacological treatment of opioid addiction: A clinical perspective. Eur. J. Clin. Pharmacol., 66, 537–545.

Musto, D. F. (1991). Opium, cocaine, and marijuana in American history. Sci. Am., 265, 40–47.

Stein, C. (2016). Opioid receptors. Annu. Rev. Med., 67, 433–451.

Wager, T. D., Scott, D. J., and Zubieta, J. K. (2007). Placebo effects on human mu-opioid activity during pain. Proc. Natl. Acad. Sci. USA, 104, 11056–11061.

Williams, R. (2010). Robert Lefkowitz: Godfather of G protein–coupled receptors. Circ. Res., 106, 812–814.